These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 20560830

  • 1. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
    Kim CK, Callaway Z, Fletcher R, Koh YY.
    J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
    [Abstract] [Full Text] [Related]

  • 2. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
    Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE.
    Lung; 2007 Jun; 185(2):97-103. PubMed ID: 17393238
    [Abstract] [Full Text] [Related]

  • 3. Eosinophilic cationic protein: is it useful in assessing control of childhood asthma?
    Zedan M, Settin A, El-Chennawi F, El-Desouky T, Nasef N, Fouda A.
    East Mediterr Health J; 2010 Oct; 16(10):1045-9. PubMed ID: 21222420
    [Abstract] [Full Text] [Related]

  • 4. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
    Onadeko BO, Khadadah ME, Mustafa HT, Ezeamuzie CI, Marouf R, Khamis A, Sugathan TN.
    East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
    [Abstract] [Full Text] [Related]

  • 5. Correlation of eosinophil cationic protein with severity of asthma.
    Badar A, Saeed W, Hussain MM, Aslam M.
    J Ayub Med Coll Abbottabad; 2004 Sep; 16(3):66-71. PubMed ID: 15631377
    [Abstract] [Full Text] [Related]

  • 6. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.
    Turk J Pediatr; 2009 Sep; 51(5):460-5. PubMed ID: 20112601
    [Abstract] [Full Text] [Related]

  • 7. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.
    Fujitaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y.
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):323-9. PubMed ID: 11289333
    [Abstract] [Full Text] [Related]

  • 8. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G.
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [Abstract] [Full Text] [Related]

  • 9. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P.
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [Abstract] [Full Text] [Related]

  • 10. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
    Gon Y, Ito R, Hattori T, Hiranuma H, Kumasawa F, Kozu Y, Endo D, Koyama D, Shintani Y, Eriko T, Soda K, Maruoka S, Hashimoto S.
    Allergy Asthma Proc; 2015 Jun; 36(6):e113-20. PubMed ID: 26534742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum eosinophil cationic protein in children with atopic dermatitis.
    Murat-Susić S, Lipozencić J, Zizić V, Husar K, Marinović B.
    Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
    [Abstract] [Full Text] [Related]

  • 13. Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood.
    Joseph-Bowen J, de Klerk N, Holt PG, Sly PD.
    J Allergy Clin Immunol; 2004 Nov; 114(5):1040-5. PubMed ID: 15536407
    [Abstract] [Full Text] [Related]

  • 14. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
    Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, Putnam PE, Rothenberg ME.
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
    [Abstract] [Full Text] [Related]

  • 15. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
    Kim HS, Kim JH, Seo YM, Chun YH, Yoon JS, Kim HH, Lee JS, Kim JT.
    Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
    [Abstract] [Full Text] [Related]

  • 16. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
    Kim CK, Callaway Z, Kim DW, Kita H.
    J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
    [Abstract] [Full Text] [Related]

  • 17. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma.
    Kim CK, Callaway Z, Park JS, Kwon E.
    Allergol Int; 2017 Jan; 66(1):70-74. PubMed ID: 27329145
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of eosinophil cationic protein levels with clinical symptoms and laboratory findings of patients with cystic echinococcosis].
    Cicioğlu Aridoğan B, Kaya S, Sesli Cetin E, Taş T, Demirci M.
    Mikrobiyol Bul; 2009 Apr; 43(2):285-92. PubMed ID: 19621614
    [Abstract] [Full Text] [Related]

  • 19. Manifold significance of serum eosinophil cationic protein in asthmatic children.
    Zubović I, Rozmanić V, Ahel V, Banac S.
    Acta Med Croatica; 2002 Apr; 56(2):53-6. PubMed ID: 12596625
    [Abstract] [Full Text] [Related]

  • 20. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
    Cottin V, Deviller P, Tardy F, Cordier JF.
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.